The Latest Cardiac and Vascular News
TUSTIN, Calif.–(BUSINESS WIRE)– A robust suite of quantitative tools to assess the spectrum of liver disease (including Steatosis, Inflammation and Cirrhosis) on Canon Medical Systems U.S.A., Inc.’s premium AplioTM i800 ultrasound system received FDA clearance. The industry’s most comprehensive Liver Analysis Suite is available on the Aplio i800, and may be helpful in the […]
LOS ANGELES–(BUSINESS WIRE)–A scientific presentation of a new vascular embolic device was presented today at the 2018 Society of Interventional Radiology conference in Los Angeles, California – GPX: A New Proprietary In Situ Setting Embolic Agent that Combines the Benefits of Coils, Gel-Beads, and Other Embolics. “GPX is a biocompatible particle embolic loaded in […]
SAN DIEGO–(BUSINESS WIRE)–Unprecedented. That’s what Access Scientific is calling the dramatic results from a leading biofilm laboratory that explain why the company’s POWERWAND™ midlines and extended-dwell catheters consistently report zero associated bloodstream infections (BSIs). Independent, peer-reviewed published studies and scientific posters on the company’s POWERWAND™ catheters – which now tally […]
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, has announced the first patient enrollment in the Perceval® Valve Clinical study for Chinese Registration (“PERFECT”) Trial. The study is a pre-market, prospective, single-arm trial. The PERFECT trial is being conducted to demonstrate the safety and effectiveness of […]
IRVINE, Calif., March 21, 2018 — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that enrollment is complete in the computed tomography (CT) imaging sub-study within the PARTNER 3 trial of the SAPIEN 3 valve. This randomized sub-study is examining […]
BARCELONA, Spain and MARLBOROUGH, Mass., March 20, 2018 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain. The data demonstrated the RHYTHMIA™ Mapping System, when paired with the INTELLAMAP […]
ABBOTT PARK, Ill., March 21, 2018 /PRNewswire/ — Abbott (NYSE: ABT) will announce its first-quarter 2018 financial results on Wednesday, April 18, 2018, before the market opens. The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m.Eastern), and will be accessible through Abbott’s Investor Relations website […]
ALAMEDA, Calif., March 21, 2018 /PRNewswire/ — Measurement of cardiac troponin in stable patients with chest pain using the ultra-sensitive Singulex cTnI assay and Single Molecule Counting technology can independently predict moderate and severe coronary disease (CAD), suggesting its clinical utility for accurate, safe and cost-effective evaluation of patients in an outpatient setting, […]
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. [OTC: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, announced it filed its annual 10-K for the year ended December 31, 2017 with the Securities and Exchange Commission on Friday, March 16, 2018. BioCardia reported a net loss of $12.3 million […]
DURHAM, N.C., March 20, 2018 /PRNewswire/ — Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently expanded intellectual property portfolio. With the granting of 24 patents in 2017, including eight that issued in the fourth quarter, Micell’s extensive intellectual property portfolio comprises 186 patents (166 issued […]
